Aldeyra Therapeutics is planning to resubmit an NDA for its dry eye disease drug in the second half of this year, though ...
Xilio Ther­a­peu­tics had a bevy of an­nounce­ments on Thurs­day — it en­tered a li­cens­ing deal for its Phase 1 IL-12 ...
Pelago, which provides digital substance use treatment for substances like opioids and tobacco, said it is expanding to cover ...
There’s no word yet on when Metagenomi will enter the clinic. In its first quarterly update as a public company, the ...
Ovid Therapeutics is ramping up its patent fight with Marinus Pharmaceuticals. The rival biotechs have been battling for more ...
Plus, news about Praxis, Pieris, Ironwood, Stoke and Milestone Pharmaceuticals: Bayer to cut 90 jobs after leadership cuts: The German conglomerate’s layoff plans were unveiled in a New Jersey Worker ...
Intellihealth signed on its largest client last year when it began providing weight-loss care and prescribing GLP-1s to ...
About a month after Oncopeptides lost its appeal with the FDA to continue the approval for Pepaxto in multiple myeloma ...
Moderna laid out its expectations for several vaccine markets Wednesday morning at an investor event as it continues moving ...
SK Life Science celebrated annual “Purple Day” for epilepsy awareness on Tuesday with a new mentoring program and a ...
India-based CDMOs have detected an uptick in biopharma client interest in their biologics and early-phase clinical offerings ...
$BOLD will take flight on Thurs­day morn­ing. Bound­less Bio, a San Diego can­cer biotech, will raise about $100 mil­lion in ...